跳至主要内容
临床试验/NCT02666807
NCT02666807已完成不适用

Effects of Oral Ginger Supplementation on NF-KB (Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells) in Peripheral Blood Mononuclear Cells (PBMC) and Glycemic and Lipid Profiles in Patients With Type 2 Diabetes Mellitus

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 2015年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
主要终点
Change from Baseline in NF-KB at 10 weeks

研究概览

简要总结

This study evaluates the effect of ginger on NF-KB level in Peripheral Blood Mononuclear Cells in type 2 diabetic patients. Half of patients will receive ginger, while the other half will receive placebo.

详细描述

ginger is a plant with lots of phytochemicals which have antioxidant effects. It reduces the NF-KB levels in the cells because of its antioxidant effects. It can reduces insulin resistance as a result of NF-KB reduction in diabetes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
30 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • type 2 of diabetes diagnosed for 1 to 10 years
  • age 30-60 years
  • BMI = 18.5-35 kg/m*m
  • treatment with Metformin or Glibenclamide

排除标准

  • Treatment with insulin
  • Weight loss more than 10% in 6 months
  • Treatment with TZDs (thiazolidinediones)
  • Pregnancy and breast feeding
  • Smoking and alcohol consumption
  • Multivitamin-mineral and polyphenols and omega-3 and 6 supplementation in the last 3 months and during study
  • Ginger supplementation and herbal medicines
  • Anticoagulation consumption such as heparin and warfarin
  • NSAIDs such as diclofenac and salicylate drugs such as aspirin, corticosteroids such as prednisone consumption during 1 month ago and during the study
  • Infectious and inflammatory diseases such as rheumatoid arthritis
  • Impaired hepatic, renal and gastrointestinal function
  • Currently suffering from acute illness that needs medical treatment

结局指标

主要结局

Change from Baseline in NF-KB at 10 weeks

时间窗: Baseline and 10 weeks

次要结局

  • Change from Baseline in LDL-C (mg/dl) at 10 weeks(Baseline and 10 weeks)
  • Change from Baseline in HDL-C (mg/dl) at 10 weeks(Baseline and 10 weeks)
  • Change from Baseline in TG (mg/dl) at 10 weeks(Baseline and 10 weeks)
  • Change from Baseline in insulin (µlU/ml) at 10 weeks(Baseline and 10 weeks)
  • Change from Baseline in Hb A1C at 10 weeks(Baseline and 10 weeks)
  • Change from Baseline in FBS (mg/dl) at 10 weeks(Baseline and 10 weeks)
  • Change from Baseline in Total-C (mg/dl) at 10 weeks(Baseline and 10 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Niaz Mohammadzadeh Honarvar

Assistant Professor

Tehran University of Medical Sciences

相似试验